These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30949194)

  • 61. Functions and mechanisms of RNA editing.
    Gott JM; Emeson RB
    Annu Rev Genet; 2000; 34():499-531. PubMed ID: 11092837
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A developmentally regulated activity that unwinds RNA duplexes.
    Bass BL; Weintraub H
    Cell; 1987 Feb; 48(4):607-13. PubMed ID: 2434241
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Site-selective versus promiscuous A-to-I editing.
    Wahlstedt H; Ohman M
    Wiley Interdiscip Rev RNA; 2011; 2(6):761-71. PubMed ID: 21976281
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A-to-I editing of coding and non-coding RNAs by ADARs.
    Nishikura K
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):83-96. PubMed ID: 26648264
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of A-to-I RNA editing in cancer development.
    Xu X; Wang Y; Liang H
    Curr Opin Genet Dev; 2018 Feb; 48():51-56. PubMed ID: 29127844
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ADAR-mediated RNA editing in non-coding RNA sequences.
    Yang Y; Zhou X; Jin Y
    Sci China Life Sci; 2013 Oct; 56(10):944-52. PubMed ID: 24008387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of RNA editing in cancer tissue at different stages in carcinogenesis.
    Kurkowiak M; Arcimowicz Ł; Chruściel E; Urban-Wójciuk Z; Papak I; Keegan L; O'Connell M; Kowalski J; Hupp T; Marek-Trzonkowska N
    RNA Biol; 2021 Nov; 18(11):1524-1539. PubMed ID: 33593231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proteome diversification by adenosine to inosine RNA editing.
    Pullirsch D; Jantsch MF
    RNA Biol; 2010; 7(2):205-12. PubMed ID: 20200492
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adenosine-to-inosine RNA editing meets cancer.
    Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
    Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
    [TBL] [Abstract][Full Text] [Related]  

  • 71. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
    Deffit SN; Hundley HA
    Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
    Heraud-Farlow JE; Walkley CR
    Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A-to-I RNA Editing: Current Knowledge Sources and Computational Approaches with Special Emphasis on Non-Coding RNA Molecules.
    Nigita G; Veneziano D; Ferro A
    Front Bioeng Biotechnol; 2015; 3():37. PubMed ID: 25859542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. All I's on the RADAR: role of ADAR in gene regulation.
    Shevchenko G; Morris KV
    FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic Positional Dissection of RNA Editomes in Tumor and Normal Samples.
    Chigaev M; Yu H; Samuels DC; Sheng Q; Oyebamiji O; Ness S; Yue W; Zhao YY; Guo Y
    Front Genet; 2019; 10():211. PubMed ID: 30949194
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
    Liao Y; Jung SH; Kim T
    Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evolutionary driving forces of A-to-I editing in metazoans.
    Duan Y; Tang X; Lu J
    Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1666. PubMed ID: 33998151
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.